FDA
-
-
-
-
-
-
-
Lifeward enters $47 million strategic partnership with Oramed
-
-
-
-
-
-
-
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
-
-
-
-
-
-
-
Lifeward Ltd. Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Lifeward (LFWD) Names Mark Grant as New CEO
-
-
-
-
-
-
-
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
-
-
-
-
-
-
-
Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities
-
-
-
-
-
-
-
Lifeward Reports First Quarter 2024 Financial Results
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

